Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H16N4O3 |
| Molecular Weight | 240.259 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C=NC=C1C[C@H](NC(=O)CCN)C(O)=O
InChI
InChIKey=MYYIAHXIVFADCU-QMMMGPOBSA-N
InChI=1S/C10H16N4O3/c1-14-6-12-5-7(14)4-8(10(16)17)13-9(15)2-3-11/h5-6,8H,2-4,11H2,1H3,(H,13,15)(H,16,17)/t8-/m0/s1
| Molecular Formula | C10H16N4O3 |
| Molecular Weight | 240.259 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Ferritin enhances salsolinol-mediated DNA strand breakage: protection by carnosine and related compounds. | 2009-07-10 |
|
| New glycosidic derivatives of histidine-containing dipeptides with antioxidant properties and resistant to carnosinase activity. | 2008-02 |
|
| The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis. | 2006-05 |
|
| Anserine bursitis in patients with osteoarthritis of the knee. | 2000-02 |
|
| Metabolic transformation of neuropeptide carnosine modifies its biological activity. | 1999-02 |
|
| [Is therapy with local infiltrations feasible in primary care consultations?]. | 1999-01 |
|
| Flexion instability after primary posterior cruciate retaining total knee arthroplasty. | 1998-11 |
|
| Carnosine and anserine as modulators of neutrophil function. | 1998-08 |
|
| Human urinary excretion of L-histidine-related compounds after ingestion of several meats and fish muscle. | 1993-09 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:31:35 GMT 2025
by
admin
on
Mon Mar 31 20:31:35 GMT 2025
|
| Record UNII |
HDQ4N37UGV
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
15139-9
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
27047-0
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
13707-5
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
13386-8
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
1864-8
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
DSLD |
293 (Number of products:1)
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
1867-1
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
28596-5
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
15133-2
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
NCI_THESAURUS |
C275
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
1865-5
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
WIKIPEDIA |
Designer-drugs-Anserine
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
NCI_THESAURUS |
C73539
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
26787-2
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
43906-7
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
26576-9
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
25858-2
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
56903-8
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
6871-8
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
1866-3
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
26599-1
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
25320-3
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
25859-0
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
||
|
LOINC |
26588-4
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
209-545-0
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY | |||
|
18323
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY | |||
|
300000051312
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY | |||
|
m1941
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
C118877
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY | |||
|
ANSERINE
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY | |||
|
DTXSID30973950
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY | |||
|
58445
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY | |||
|
584-85-0
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY | |||
|
HDQ4N37UGV
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY | |||
|
112072
Created by
admin on Mon Mar 31 20:31:35 GMT 2025 , Edited by admin on Mon Mar 31 20:31:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TRANSPORTER -> INHIBITOR |
